Pfizer Dodges Fraud Prosecution AGAIN By Paying Over $1 Billion Fine

A division of Pfizer Inc., the world’s largest drugmaker, has agreed to plead
guilty to two felonies and pay $430 million in penalties to settle charges that
it fraudulently promoted the drug Neurontin for a string of unapproved uses.

In an agreement announced by government prosecutors Thursday, Pfizer unit
Warner-Lambert admitted that it aggressively marketed the epilepsy drug by

illicit means for unrelated conditions including bipolar disorder, pain,
migraine headaches, and drug and alcohol withdrawal.
A company whistle-blower, whose 1996 civil suit spurred
government investigations of Neurontin’s marketing campaign, will receive about
$26.6 million through the settlement under legal provisions that reward citizens
for helping to recover government money obtained by fraud.

The settlement includes $152 million to pay back amounts spent on Neurontin
by the federal Medicare program and 50 state Medicaid programs for the poor. In
addition, Pfizer will pay a $240 million criminal fine, the second-largest such

fine ever imposed in a health care fraud prosecution, the Department of Justice
said.

Read More

Prozac, Effexor, Klonopin, Serzone, Zyprexa, Neurontin, and now Celexa-and Hospitalized Seven Times.

“I sometimes am so sorry I started him on this medication journey,”   I have had thoughts that maybe my son’s suicide attempts were related to the Prozac and other medications that he had been taking, and now after reading correspondence from others regarding the same behaviors, I am more convinced that there was a…

Read More

Notice: ob_end_flush(): Failed to send buffer of zlib output compression (0) in /homepages/24/d109934528/htdocs/icfda/wp-includes/functions.php on line 5464